Direct-to-Consumer Genetic Testing Market Size, Share, Demand and Report by 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Direct-to-Consumer Genetic Testing Market Size Analysis

Global Direct-to-Consumer Genetic Testing Market Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Nutrigenomics Testing
  1. By Value
3. Predictive Testing
  1. By Value
4. Carrier Testing
  1. By Value
5. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Whole Genome Sequencing
  1. By Value
3. Single Nucleotide Polymorphism Chips
  1. By Value
4. Targeted Analysis
  1. By Value
5. Others
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Online Platform
  1. By Value
3. OTC
  1. By Value

North America Market Analysis

Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Nutrigenomics Testing
  1. By Value
3. Predictive Testing
  1. By Value
4. Carrier Testing
  1. By Value
5. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Whole Genome Sequencing
  1. By Value
3. Single Nucleotide Polymorphism Chips
  1. By Value
4. Targeted Analysis
  1. By Value
5. Others
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Online Platform
  1. By Value
3. OTC
  1. By Value
U.S.
1. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Nutrigenomics Testing
    1. By Value
  3. Predictive Testing
    1. By Value
  4. Carrier Testing
    1. By Value
  5. Others
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Whole Genome Sequencing
    1. By Value
  3. Single Nucleotide Polymorphism Chips
    1. By Value
  4. Targeted Analysis
    1. By Value
  5. Others
    1. By Value
3. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Online Platform
    1. By Value
  3. OTC
    1. By Value
Canada

Europe Market Analysis

Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Nutrigenomics Testing
  1. By Value
3. Predictive Testing
  1. By Value
4. Carrier Testing
  1. By Value
5. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Whole Genome Sequencing
  1. By Value
3. Single Nucleotide Polymorphism Chips
  1. By Value
4. Targeted Analysis
  1. By Value
5. Others
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Online Platform
  1. By Value
3. OTC
  1. By Value
U.K.
1. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Nutrigenomics Testing
    1. By Value
  3. Predictive Testing
    1. By Value
  4. Carrier Testing
    1. By Value
  5. Others
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Whole Genome Sequencing
    1. By Value
  3. Single Nucleotide Polymorphism Chips
    1. By Value
  4. Targeted Analysis
    1. By Value
  5. Others
    1. By Value
3. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Online Platform
    1. By Value
  3. OTC
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Nutrigenomics Testing
  1. By Value
3. Predictive Testing
  1. By Value
4. Carrier Testing
  1. By Value
5. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Whole Genome Sequencing
  1. By Value
3. Single Nucleotide Polymorphism Chips
  1. By Value
4. Targeted Analysis
  1. By Value
5. Others
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Online Platform
  1. By Value
3. OTC
  1. By Value
China
1. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Nutrigenomics Testing
    1. By Value
  3. Predictive Testing
    1. By Value
  4. Carrier Testing
    1. By Value
  5. Others
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Whole Genome Sequencing
    1. By Value
  3. Single Nucleotide Polymorphism Chips
    1. By Value
  4. Targeted Analysis
    1. By Value
  5. Others
    1. By Value
3. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Online Platform
    1. By Value
  3. OTC
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Nutrigenomics Testing
  1. By Value
3. Predictive Testing
  1. By Value
4. Carrier Testing
  1. By Value
5. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Whole Genome Sequencing
  1. By Value
3. Single Nucleotide Polymorphism Chips
  1. By Value
4. Targeted Analysis
  1. By Value
5. Others
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Online Platform
  1. By Value
3. OTC
  1. By Value
UAE
1. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Nutrigenomics Testing
    1. By Value
  3. Predictive Testing
    1. By Value
  4. Carrier Testing
    1. By Value
  5. Others
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Whole Genome Sequencing
    1. By Value
  3. Single Nucleotide Polymorphism Chips
    1. By Value
  4. Targeted Analysis
    1. By Value
  5. Others
    1. By Value
3. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Online Platform
    1. By Value
  3. OTC
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Test Type
1. Introduction
  1. Test Type By Value
2. Nutrigenomics Testing
  1. By Value
3. Predictive Testing
  1. By Value
4. Carrier Testing
  1. By Value
5. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. Whole Genome Sequencing
  1. By Value
3. Single Nucleotide Polymorphism Chips
  1. By Value
4. Targeted Analysis
  1. By Value
5. Others
  1. By Value
By Distribution Channel
1. Introduction
  1. Distribution Channel By Value
2. Online Platform
  1. By Value
3. OTC
  1. By Value
Brazil
1. By Test Type
  1. Introduction
    1. Test Type By Value
  2. Nutrigenomics Testing
    1. By Value
  3. Predictive Testing
    1. By Value
  4. Carrier Testing
    1. By Value
  5. Others
    1. By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Whole Genome Sequencing
    1. By Value
  3. Single Nucleotide Polymorphism Chips
    1. By Value
  4. Targeted Analysis
    1. By Value
  5. Others
    1. By Value
3. By Distribution Channel
  1. Introduction
    1. Distribution Channel By Value
  2. Online Platform
    1. By Value
  3. OTC
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Direct-to-Consumer Genetic Testing Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Regeneron Pharmaceuticals
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Family Tree DNA
Ancestry
Ultima Genomics, Inc.,
Gene by Gene
Genesis HealthCare
EasyDNA,
Veritas
Myriad Genetics Inc.
Full Genomes Corporation, Inc
Living DNA Ltd.
Color Health, Inc.
Quest Diagnostics
Hydreight Technologies Inc.
Sunhealth
Nucleus Genomics
Divine Genes Sdn Bhd

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment